Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D N Danforth

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Cancer Research|April 1, 1993
Interleukin-1 alpha and interleukin-6 act additively to inhibit growth of MCF-7 breast cancer cells in vitroD N Danforth, M K Sgagias
The American Surgeon|February 11, 1991
Splenectomy for the massively enlarged spleenD N Danforth, D L Fraker
Cancer Research|March 11, 1991
Interleukin 1 alpha blocks estradiol-stimulated growth and down-regulates the estrogen receptor in MCF-7 breast cancer cells in vitroD N Danforth, M K Sgagias
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1996
Tumor necrosis factor alpha enhances secretion of transforming growth factor beta2 in MCF-7 breast cancer cellsD N Danforth, M K Sgagias
Nature|September 22, 1983
Melatonin increases oestrogen receptor binding activity of human breast cancer cellsD N Danforth, L Tamarkin, M E Lippman
Ciba Foundation Symposium|January 1, 1985
Melatonin and malignant diseaseL Tamarkin, O F Almeida, D N Danforth
Surgery|December 1, 1984
Metastatic insulin-secreting carcinoma of the pancreas: clinical course and the role of surgeryD N Danforth, P Gorden, M F Brennan
Southern Medical Journal|June 1, 1982
Hormonal status of patients with primary malignant melanoma: a review of 313 casesD N Danforth, N Russell, C M McBride
Molecular Endocrinology (Baltimore, Md.)|November 11, 1991
Interleukin-1 alpha and tumor necrosis factor-alpha (TNF alpha) inhibit growth and induce TNF messenger RNA in MCF-7 human breast cancer cellsM K Sgagias, A Kasid, D N Danforth
Endocrinology|October 29, 2010
Fluctuations in weight, hematocrit and plasma protein with the menstrual cycleD N DANFORTH, P K BOYER, S GRAFF
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Cancer Research|April 1, 1993
Interleukin-1 alpha and interleukin-6 act additively to inhibit growth of MCF-7 breast cancer cells in vitroD N Danforth, M K Sgagias
The American Surgeon|February 11, 1991
Splenectomy for the massively enlarged spleenD N Danforth, D L Fraker
Cancer Research|March 11, 1991
Interleukin 1 alpha blocks estradiol-stimulated growth and down-regulates the estrogen receptor in MCF-7 breast cancer cells in vitroD N Danforth, M K Sgagias
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1996
Tumor necrosis factor alpha enhances secretion of transforming growth factor beta2 in MCF-7 breast cancer cellsD N Danforth, M K Sgagias
Nature|September 22, 1983
Melatonin increases oestrogen receptor binding activity of human breast cancer cellsD N Danforth, L Tamarkin, M E Lippman
Ciba Foundation Symposium|January 1, 1985
Melatonin and malignant diseaseL Tamarkin, O F Almeida, D N Danforth
Surgery|December 1, 1984
Metastatic insulin-secreting carcinoma of the pancreas: clinical course and the role of surgeryD N Danforth, P Gorden, M F Brennan
Southern Medical Journal|June 1, 1982
Hormonal status of patients with primary malignant melanoma: a review of 313 casesD N Danforth, N Russell, C M McBride
Molecular Endocrinology (Baltimore, Md.)|November 11, 1991
Interleukin-1 alpha and tumor necrosis factor-alpha (TNF alpha) inhibit growth and induce TNF messenger RNA in MCF-7 human breast cancer cellsM K Sgagias, A Kasid, D N Danforth
Endocrinology|October 29, 2010
Fluctuations in weight, hematocrit and plasma protein with the menstrual cycleD N DANFORTH, P K BOYER, S GRAFF
Pageof 6